Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Dicer deletion in hepatocytes promotes macrophages M1 polarization through dysregulated miR-192-3p/IGF2 in non-alcoholic steatohepatitis and hepatocellular carcinoma

Abstract

Macrophages plays a vital role in the development of non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), but the polarization of macrophages was not consistent in previous reports and the contribution of hepatocytes to macrophage polarization is not clear. Here, we show that in clinical NASH and HCC samples, impaired Dicer activity was common and correlated with increased M1-like macrophages. Mice with Dicer deletion in hepatocytes could induce macrophages M1 polarization either in the development of NASH under high fat diet feeding, or in the carcinogenesis of HCC after DEN treatment. In hepatic cells, Dicer deletion delivered distinct lipid profile and increased lipid oxidation. Mechanically, Dicer deletion caused declined miR-192-3p and increased IGF2 in hepatocytes. Restoring miR-192-3p could suppress IGF2 and inhibit macrophage infiltration in the liver tissue, as well as reduce the lipid de novo synthesis and peroxidation. Overall, our data highlights the central role of Dicer-associated miR-192-3p in the etiopathogenesis of macrophage M1 polarization in NASH and HCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The expression of Dicer decreases in HCC and NASH.
Fig. 2: Dicer LKO mice develop NASH and HCC spontaneously with macrophages M1 polarization.
Fig. 3: Dicer LKO mice show macrophages M1 polarization and NASH under high fat diet.
Fig. 4: Dicer LKO mice are more susceptible to DEN-induced HCC with macrophages M1 polarization in the microenvironment.
Fig. 5: Dicer LKO mice show distinct lipid profile and increased lipid oxidation.
Fig. 6: Dicer deletion causes dysregulated miR-192-3p/IGF2 in hepatocytes.
Fig. 7: Over expression of miR-192-3p suppresses IGF2 and ameliorates NASH in Dicer LKO mice.

Similar content being viewed by others

Data availability

All data in this study is available upon request.

References

  1. Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71:1851–64.

    Article  Google Scholar 

  2. Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020;323:1175–83.

    Article  CAS  Google Scholar 

  3. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46:1081–90.

    Article  CAS  Google Scholar 

  4. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14–20.

    Article  CAS  Google Scholar 

  5. Kazankov K, Jorgensen SMD, Thomsen KL, Moller HJ, Vilstrup H, George J, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16:145–59.

    Article  CAS  Google Scholar 

  6. Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10:542–52.

    Article  CAS  Google Scholar 

  7. Sekine S, Ogawa R, Ito R, Hiraoka N, McManus MT, Kanai Y, et al. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology. 2009;136:2304–15.e1-4.

    Article  CAS  Google Scholar 

  8. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87–98.

    Article  CAS  Google Scholar 

  9. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871–83.

    Article  CAS  Google Scholar 

  10. Sun LN, Xing C, Zhi Z, Liu Y, Chen LY, Shen T, et al. Dicer suppresses cytoskeleton remodeling and tumorigenesis of colorectal epithelium by miR-324-5p mediated suppression of HMGXB3 and WASF-2. Oncotarget. 2017;8:55776–89.

    Article  Google Scholar 

  11. Liu Y, Song L, Ni H, Sun L, Jiao W, Chen L, et al. ERBB4 acts as a suppressor in the development of hepatocellular carcinoma. Carcinogenesis. 2017;38:465–73.

    Article  Google Scholar 

  12. Liu Y, Song C, Ni H, Jiao W, Gan W, Dong X, et al. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma. J Viral Hepat. 2018;25:1363–71.

    Article  CAS  Google Scholar 

  13. Gill RM, Kakar S. Nonalcoholic steatohepatitis: diagnostic challenges. Surg Pathol Clin. 2013;6:227–57.

    Article  Google Scholar 

  14. Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878.

    Article  Google Scholar 

  15. Ni H, Chen Y, Xia W, Wang C, Hu C, Sun L, et al. SATB2 defect promotes colitis and colitis-associated colorectal cancer by impairing Cl-/HCO3- exchange and homeostasis of gut microbiota. J Crohns Colitis. 2021;15:2088–102.

    Article  Google Scholar 

  16. Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436–45.

    Article  CAS  Google Scholar 

  17. Lopez BG, Tsai MS, Baratta JL, Longmuir KJ, Robertson RT. Characterization of Kupffer cells in livers of developing mice. Comp Hepatol. 2011;10:2.

    Article  Google Scholar 

  18. Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59:1393–405.

    Article  Google Scholar 

  19. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49–61.

    Article  CAS  Google Scholar 

  20. Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59:130–42.

    Article  CAS  Google Scholar 

  21. Ringelhan M, Pfister D, O’Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222–32.

    Article  CAS  Google Scholar 

  22. Gorden DL, Myers DS, Ivanova PT, Fahy E, Maurya MR, Gupta S, et al. Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J Lipid Res. 2015;56:722–36.

    Article  CAS  Google Scholar 

  23. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene. 2005;24:6314–22.

    Article  CAS  Google Scholar 

  24. Gu L, Zhu Y, Lin X, Lu B, Zhou X, Zhou F, et al. The IKKbeta-USP30-ACLY axis controls lipogenesis and tumorigenesis. Hepatology. 2021;73:160–74.

    Article  CAS  Google Scholar 

  25. Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20:R321–39.

    Article  CAS  Google Scholar 

  26. Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010;21:610–8.

    Article  CAS  Google Scholar 

  27. Bae MH, Lee MJ, Bae SK, Lee OH, Lee YM, Park BC, et al. Insulin-like growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Lett. 1998;128:41–6.

    Article  CAS  Google Scholar 

  28. Wang X, Lin L, Lan B, Wang Y, Du L, Chen X, et al. IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages. Sci Adv. 2020;6:eabb7389.

    Article  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation (No. 81972259, 31471189), the National Science Fund for Distinguished Young Scholars (No. 81525020), and the discipline construction and support project (No. XKTJ-JD202006) and the Hospital Youth aid project (No. SDFEYQN1901) of Second Affiliated Hospital of Soochow University. This work was also supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

Author information

Authors and Affiliations

Authors

Contributions

YL and JL: study concept and design; CH, XL, YC, YZ, YY, QZ, HN, and WG: acquisition of data; YS, LS, and YL: analysis and interpretation of data; YL: drafting of the manuscript; CH and YL: statistical analysis; WG and LS: technical or material support; YL and JL: obtained funding.

Corresponding authors

Correspondence to Jianming Li or Yao Liu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, C., Li, X., Sui, Y. et al. Dicer deletion in hepatocytes promotes macrophages M1 polarization through dysregulated miR-192-3p/IGF2 in non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Gene Ther 29, 1252–1262 (2022). https://doi.org/10.1038/s41417-022-00432-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41417-022-00432-x

Search

Quick links